Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Frontiers in Immunology|May 28, 2020
Muscle-Specific Kinase Myasthenia GravisLucia S Borges, David P RichmanJournal of Neurobiology|December 19, 2001
Dual role for calcium in agrin signaling and acetylcholine receptor clusteringLucia S Borges, Young Lee, Michael FernsAnnals of the New York Academy of Sciences|November 1, 2003
Treatment principles in the management of autoimmune myasthenia gravisDavid P Richman, Mark A AgiusBiochimica Et Biophysica Acta|December 9, 2014
Myasthenia gravis and related disorders: Pathology and molecular pathogenesisJames C Ha, David P RichmanJournal of Clinical Neurology (Seoul, Korea)|January 20, 2012
Treatment of myasthenia gravis based on its immunopathogenesisJee Young Kim, Kee Duk Park, David P RichmanNeurology|February 7, 2016
Myasthenia gravis exacerbation after discontinuing mycophenolate: A single-center cohort studyBjörn Oskarsson, David M Rocke, Karsten Dengel, et al.Experimental Neurology|January 17, 2015
How clinical trials of myasthenia gravis can inform pre-clinical drug developmentAnna Rostedt Punga, Henry J Kaminski, David P Richman, et al.Journal of the Neurological Sciences|May 3, 2011
Accelerated central nervous system autoimmunity in BAFF-receptor-deficient miceSusan S Kim, David P Richman, Scott S Zamvil, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 19, 2017
Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen ActivatorDavid Bissig, Rashmi Manjunath, Brittany R Traylor, et al.Pageof 3